| Drug Name | Valdoxan (AGOMELATINE) |
|---|---|
| Drug Class |
Anti-depressant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Psychiatry
|
| Risk |
New contraindication for use and a reminder of importance of liver function monitoring. |
| Dear Healthcare provider letter DHPC |
|